Capsules 40mg

As palliative or supplementary treatment, usually in combination with radiotherapy and/or surgery as part of multiple drug regimens in:

• Brain tumours (primary or metastatic)
• Lung tumours (especially oat-cell carcinoma)
• Hodgkin’s disease (resistant to conventional combination chemotherapy)
• Malignant melanoma (metastatic)

Lomustine “medac” may also be of value as second-line treatment in Non-Hodgkin’s lymphoma, myelomatosis, gastrointestinal tumours, carcinoma of the kidney, the testis, the ovary, the cervix uteri and the breast.